Track insider transactions across markets
| Subscribe to access full data | ||||||
|---|---|---|---|---|---|---|
| Company | Business Sector | Market cap ($) | # net buying insiders | Net value bought ($) | % of float bought | % of shares held by insiders |
|
|
Healthcare Services | Nano (32.4mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (32.3mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (32.3mn) | 0 | No activity | — | 50%+ |
|
|
Healthcare Services | Nano (32.0mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (31.9mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (31.7mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (31.0mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (30.8mn) | 0 | $1M–$10M | 15–50% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (30.6mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (30.4mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (30.3mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (30.2mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (30.2mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (30.2mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (30.1mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (30.1mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (30.1mn) | 0 | No activity | — | 0–15% |
| Healthcare Services | Nano (30.0mn) | 0 | No activity | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (29.7mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (29.4mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (29.4mn) | 0 | No activity | — | 50%+ |
|
|
Healthcare Services | Nano (29.1mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (28.9mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (28.9mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (28.8mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (28.8mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (28.8mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (28.5mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (28.4mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (28.4mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (28.4mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (28.3mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (28.3mn) | 0 | No activity | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (28.2mn) | 0 | No activity | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (28.1mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Healthcare Services | Nano (28.0mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (27.8mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (27.8mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (27.6mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (27.5mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (27.2mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (27.2mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (27.1mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (26.9mn) | 1–5 | < $100K | 0–15% | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (26.9mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (26.8mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (26.7mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (26.6mn) | 0 | No activity | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (26.6mn) | 0 | No activity | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (26.6mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (26.5mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (26.5mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (26.3mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (26.3mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (26.1mn) | 0 | No activity | — | 50%+ |
|
|
Healthcare Services | Nano (26.0mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (25.8mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (25.8mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (25.7mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (25.5mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (25.5mn) | 0 | No activity | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (25.4mn) | 0 | No activity | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (25.3mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (25.3mn) | 1–5 | $100K–$1M | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (25.0mn) | 0 | No activity | — | 0–15% |
| Healthcare Services | Nano (25.0mn) | 0 | No activity | — | 50%+ | |
|
|
Healthcare Services | Nano (24.9mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (24.8mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (24.7mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Healthcare Services | Nano (24.6mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (24.5mn) | 0 | No activity | — | 50%+ |
| Pharmaceuticals & Medical Research | Nano (24.3mn) | 0 | No activity | — | 50%+ | |
|
|
Pharmaceuticals & Medical Research | Nano (24.3mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (24.3mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (24.2mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (23.9mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (23.8mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (23.3mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (23.3mn) | 0 | No activity | — | 15–50% |
| Healthcare Services | Nano (23.2mn) | 0 | No activity | — | 15–50% | |
|
|
Healthcare Services | Nano (23.2mn) | 1–5 | $100K–$1M | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (23.1mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (22.9mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (22.9mn) | 0 | No activity | — | 50%+ |
|
|
Healthcare Services | Nano (22.8mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (22.8mn) | -1–5 | -< $100K | -0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (22.6mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (22.6mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (22.5mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (22.5mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (22.3mn) | 0 | No activity | — | 0–15% |
| Healthcare Services | Nano (22.3mn) | 0 | No activity | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (22.2mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (22.2mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (22.1mn) | 0 | No activity | — | 50%+ |
| Healthcare Services | Nano (22.1mn) | 0 | No activity | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (21.7mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (21.6mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (21.6mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (21.6mn) | 0 | No activity | — | 0–15% |